Ipsen SA
102.10
30-April-25 10:29:51
15 minutes delayed
Stocks
+2.55
+2.56%
Today's range
100.40 - 102.35
ISIN
FR0010259150
Source
Cboe
-
30 Apr 2025 11:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2025 01:14:23 By Nasdaq GlobeNewswire
-
Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
15 Apr 2025 23:57:00 By Nasdaq GlobeNewswire
-
14 Apr 2025 11:00:00 By Nasdaq GlobeNewswire
-
Ipsen publishes its 2024 Universal Registration Document
08 Apr 2025 11:00:00 By Nasdaq GlobeNewswire
-
Ipsen announces issuance of €500 million inaugural Rated Public Bond
19 Mar 2025 01:00:00 By Nasdaq GlobeNewswire
-
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
12 Mar 2025 01:28:00 By Nasdaq GlobeNewswire
-
06 Mar 2025 11:00:00 By Nasdaq GlobeNewswire
-
Ipsen S.A. publishes its 2024 consolidated financial statements
21 Feb 2025 08:42:27 By Nasdaq GlobeNewswire
-
12 Feb 2025 23:57:00 By Nasdaq GlobeNewswire
-
06 Feb 2025 11:00:00 By Nasdaq GlobeNewswire
-
07 Jan 2025 11:00:00 By Nasdaq GlobeNewswire
-
Ipsen - Half year statement - 2024 12 31
07 Jan 2025 11:00:00 By Nasdaq GlobeNewswire
-
09 Dec 2024 11:00:00 By Nasdaq GlobeNewswire
-
03 Dec 2024 00:00:00 By Nasdaq GlobeNewswire
-
15 Nov 2024 10:00:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 11:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2024 00:00:00 By Nasdaq GlobeNewswire
-
Ipsen receives its second Shingo Prize for operational excellence
14 Oct 2024 11:00:00 By Nasdaq GlobeNewswire
-
09 Oct 2024 11:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >